HomeNewsAustralia news live: Trump tariff announcement wipes $1bn from...

Australia news live: Trump tariff announcement wipes $1bn from CSL value | Australia news

Luca Ittimani

Trump tariff announcement wipes $1bn from CSL value

Australian medical companies, including struggling global biotech company CSL, have lost billions in value after Donald Trump announced 100% tariffs on pharmaceuticals entering the US.

Trump on Truth Social said companies building manufacturing plants in the US would be exempt from the tariffs, due to take effect on 1 October.

Signage for CSL is seen at the CSL Global Headquarters and Centre for Research and Development centre in Melbourne
Photograph: James Ross/AAP

CSL initially lost $3bn in market value on the news but has pared its losses to $1bn, a 1% fall in its share price, after rushing to reassure investors it expected to avoid the tariffs. A spokesperson said:

We have a very significant United States manufacturing footprint. We are already expanding our US capabilities to meet the growing demand for our therapies … As per previous market guidance, we do not expect any material impact from these tariffs.

The announcement is the latest blow to the market heavyweight. It lost about $20bn in market capitalisation in August on the day it released disappointing financial results but has continued to slide, now $35bn smaller or three-quarters the size it was two months ago.

Trump’s announcement also wiped hundreds of millions from the values of other pharmaceutical companies, with Soul Pattinson down 2.5%, losing $400m from its market capitalisation. Neuren fell 3.6% or $100m, Telix lost 2.6% or $130m and Pro Medicus fell 2.5%

The broader health sector fell 1.5% of its value on the news, although rising values for the big banks and miners have kept the all ordinaries and the benchmark S&P/ASX200 from falling.

Share

Updated at 

Key events

TGA recalls more sunscreens over SPF concerns

Catie McLeod

Catie McLeod

Two more sunscreens are being pulled from shelves for making SPF claims that may be inaccurate.

Earlier today, the Therapeutic Goods Administration (TGA) issued a recall for two of Advanced Skin Technology’s mineral sunscreens, both sold under the Aspect brand name.

The medicines regulator said Advanced Skin Technology was recalling four batches of the Aspect Sun Physical Sun Protection SPF50+ and four batches of the Aspect Sun Tinted Physical SPF50+.

The TGA says the decision “follows preliminary testing evidence indicating that the SPF levels of their products may be lower than what is claimed on their labels”.

The Aspect sunscreens are the latest in a string of mineral-based sunscreens that have been recalled or “paused” due to concerns about their efficacy, including Ultra Violette’s Lean Screen Skinscreen, which an investigation by consumer group Choice found had greatly overstated its SPF rating.

Advanced Skin Technology has been contacted for comment.

You can read more here:

Share

Source link

- Advertisement -

Worldwide News, Local News in London, Tips & Tricks